Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1254452
Max Phase: Preclinical
Molecular Formula: C20H41N5O7
Molecular Weight: 463.58
Molecule Type: Small molecule
Associated Items:
ID: ALA1254452
Max Phase: Preclinical
Molecular Formula: C20H41N5O7
Molecular Weight: 463.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H]([C@@H](C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O
Standard InChI: InChI=1S/C20H41N5O7/c1-8(21)12-5-4-9(22)18(30-12)31-15-10(23)6-11(24)16(13(15)26)32-19-14(27)17(25-3)20(2,28)7-29-19/h8-19,25-28H,4-7,21-24H2,1-3H3/t8-,9-,10+,11-,12+,13+,14-,15-,16+,17-,18-,19-,20+/m1/s1
Standard InChI Key: XUFIWSHGXVLULG-IDLVJFIQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 463.58 | Molecular Weight (Monoisotopic): 463.3006 | AlogP: -3.59 | #Rotatable Bonds: 6 |
Polar Surface Area: 213.72 | Molecular Species: BASE | HBA: 12 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.55 | CX Basic pKa: 10.01 | CX LogP: -3.57 | CX LogD: -11.56 |
Aromatic Rings: 0 | Heavy Atoms: 32 | QED Weighted: 0.19 | Np Likeness Score: 1.67 |
1. Joshi S, Fedoseyenko D, Mahanta N, Ducati RG, Feng M, Schramm VL, Begley TP.. (2019) Antibacterial Strategy against H. pylori: Inhibition of the Radical SAM Enzyme MqnE in Menaquinone Biosynthesis., 10 (3): [PMID:30891141] [10.1021/acsmedchemlett.8b00649] |
2. Shahin IG,Abutaleb NS,Alhashimi M,Kassab AE,Mohamed KO,Taher AT,Seleem MN,Mayhoub AS. (2020) Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections., 202 [PMID:32707373] [10.1016/j.ejmech.2020.112497] |
3. Guchhait S, Khononov A, Pieńko T, Belakhov V, Baasov T.. (2023) Balancing Nonsense Mutation Readthrough and Toxicity of Designer Aminoglycosides for Treatment of Genetic Diseases., 14 (6): [PMID:37312846] [10.1021/acsmedchemlett.3c00089] |
Source(1):